William J. Curatolo
37Patents
17h-index
33Co-inventors
81Inventor score
Filing activity: Jun 7, 1985 → Mar 16, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5443843A | Gastric retention system for controlled drug release | Human Necessities | 179 | Expired |
| US4895724A | Chitosan compositions for controlled and prolonged release of macromolecules | Human Necessities | 161 | Expired |
| US6706283B1 | Controlled release by extrusion of solid amorphous dispersions of drugs | Human Necessities | 116 | Expired |
| US5516527A | Dispensing device powered by hydrogel | Human Necessities | 98 | Expired |
| US6068859A | Controlled-release dosage forms of Azithromycin | Human Necessities | 77 | Expired |
| US5002772A | Gastric retention system for controlled drug release | Human Necessities | 65 | Expired |
| US6548555B1 | Basic drug compositions with enhanced bioavailability | Emerging Cross-Sectional Technologies | 62 | Expired |
| US5605889A | Method of administering azithromycin | Human Necessities | 53 | Expired |
| US8703196B2 | Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers | Human Necessities | 40 | Active |
| US6517866B1 | Sertraline salts and sustained-release dosage forms of sertraline | Human Necessities | 32 | Expired |
| US8236328B2 | Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers | Human Necessities | 28 | Active |
| US8257741B2 | Solid pharmaceutical dispersions with enhanced bioavailability | Performing Operations; Transporting | 25 | Expired |
| US7887840B2 | Pharmaceutical compositions comprising drug and concentration-enhancing polymers | Performing Operations; Transporting | 22 | Active |
| US8026286B2 | Pharmaceutical compositions providing enhanced drug concentrations | Human Necessities | 22 | Expired |
| US8263128B2 | Solid pharmaceutical dispersions with enhanced bioavailability | Performing Operations; Transporting | 22 | Expired |
| US5792471A | Dispensing devices powered by hydrogel | Human Necessities | 21 | Expired |
| US7550158B2 | Controlled release by extrusion of solid amorphous dispersions of drugs | Human Necessities | 17 | Expired |
| US7108865B2 | Controlled-release dosage forms of azithromycin | Human Necessities | 17 | Expired |
| US8202912B2 | Pharmaceutical compositions providing enhanced drug concentrations | Human Necessities | 15 | Active |
| US5030452A | Dispensing devices powered by lyotropic liquid crystals | Human Necessities | 14 | Expired |
| US6641840B2 | Sustained release formulations for growth hormone secretagogues | Human Necessities | 13 | Expired |
| US5108756A | Dispensing devices powered by lyotropic liquid crystals | Human Necessities | 12 | Expired |
| US8367118B2 | Solid pharmaceutical dispersions with enhanced bioavailability | Performing Operations; Transporting | 9 | Active |
| US8337899B2 | Solid pharmaceutical dispersions with enhanced bioavailability | Performing Operations; Transporting | 8 | Active |
| US8431159B2 | Solid pharmaceutical dispersions with enhanced bioavailability | Performing Operations; Transporting | 8 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.